Please Wait
Applying Filters...
menu
    • menu
    Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients, & custom-made solutions to our customers.

    Virtual Booth

    Contact Supplier

    Inke S.A: APIs manufacturing plant.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-21

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-04-14

    Virtual Booth

    Contact Supplier

    Menu

    Cephalexin

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 63Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Axiom Medical Celebrates 25 Years at Client Summit
    Axiom Medical Celebrates 25 Years at Client Summit

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3070386/0/en/Axiom-Medical-Marks-25-Years-of-Advancing-Workplace-Safety-and-Health-at-Annual-Client-Summit.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    DEBRA Research Invests in Nova Anchora for Epidermolysis Bullosa
    DEBRA Research Invests in Nova Anchora for Epidermolysis Bullosa

    29 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/29/3069887/0/en/DEBRA-Research-Announces-Impact-Investment-into-Nova-Anchora-to-Advance-Protein-Therapy-for-Epidermolysis-Bullosa.html

    GLOBENEWSWIRE
    29 Apr 2025
    Share Share
    Relmada Therapeutics To Present NDV-01 Data at AUA2025
    Relmada Therapeutics To Present NDV-01 Data at AUA2025

    27 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/27/3068820/0/en/UPDATE-Relmada-Therapeutics-To-Present-NDV-01-Data-at-AUA2025.html

    GLOBENEWSWIRE
    27 Apr 2025
    Share Share
    Terrapin Beer Marks 23 Years with Terraprint and Orvis Partnership
    Terrapin Beer Marks 23 Years with Terraprint and Orvis Partnership

    24 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/24/3067268/0/en/Terrapin-Beer-Co-Celebrates-23-Years-of-Craft-Beer-and-Environmental-Stewardship-with-Terraprint-Initiative-and-Orvis-Partnership.html

    GLOBENEWSWIRE
    24 Apr 2025
    Share Share
    Summit Therapeutics to Host Q1 2025 Results Call on May 1, 2025
    Summit Therapeutics to Host Q1 2025 Results Call on May 1, 2025

    24 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250424810995/en/Summit-Therapeutics-to-Host-First-Quarter-2025-Financial-Results-Operational-Progress-Call-on-May-1-2025

    BUSINESSWIRE
    24 Apr 2025
    Share Share
    Rapport Therapeutics to Join Investor Conferences
    Rapport Therapeutics to Join Investor Conferences

    22 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/22/3065349/0/en/Rapport-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    22 Apr 2025
    Share Share